We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Meaningful patient representation informing Canada's cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review.
- Authors
Hoch, J. S.; Brown, M. B.; McMahon, C.; Nanson, J.; Rozmovits, L.
- Abstract
In this interview with the patient representatives on the Expert Review Committee (PERC) of the Pan-Canadian Oncology Drug Review (PCODR), those representatives offer their views about how to be a valuable contributing member of Canada's national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about Pcodr from the perspective of the patient representatives.
- Subjects
CANADA; PATIENT representatives; MEDICAL decision making; CANCER treatment; MEDICAL care; CANADIANS; PATIENT advocacy
- Publication
Current Oncology, 2014, Vol 21, Issue 5, p263
- ISSN
1198-0052
- Publication type
Article
- DOI
10.3747/co.21.2128